Founded in 2013 by Stanislas Niox-Chateau and his three co-founders, the software assists healthcare professionals with administrative tasks, such as appointment scheduling and management.
Patients can make online appointments and check availability with Doctolib instead of contacting providers directly.
This may seem like a small breakthrough in a world where everything is booked online, but in the bureaucratic, slow, and data-sensitive healthcare sector, any program that can consistently reduce complexity and free up time is a welcome shift.
Patients can use Doctolib for free. Medical professionals can utilize the core software for €139 ($151; £120) a month, with upgrades and add-ons available.
Additionally, hospitals and other professionals, like physiotherapists, have their own packages.
By the time the pandemic struck, Doctolib was already doing well. The company profited from the unexpected surge in telemedicine, and its collaboration with the French government to streamline the COVID-19 vaccine deployment helped establish the company’s reputation in France.
According to the company, it serves nearly the whole French population and was valued at approximately £5 billion in March 2022, when it held its most recent investment round.
